# Comparison of Lormetazepam and Midazolam Used as Sedatives for Patients That Require Intensive Care

> **NCT02022592** · PHASE4 · COMPLETED · sponsor: **Claudia Spies** · enrollment: 84 (actual)

## Conditions studied

- Sedation in Intensive Care Unit Patients

## Interventions

- **DRUG:** Lormetazepam
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT02022592
- **Lead sponsor:** Claudia Spies
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07-17
- **Primary completion:** 2019-12-12
- **Final completion:** 2020-03-12
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2022-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02022592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02022592, "Comparison of Lormetazepam and Midazolam Used as Sedatives for Patients That Require Intensive Care". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02022592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*